SINOTHERAPEUTICS released its performance for the first three quarters, with a net profit attributable to the parent company of 63.46 million yuan, a year-on-year decrease of 31.45%Zhitong·Oct 30, 2025 at 03:33 AM688247+2.10%
SINOTHERAPEUTICS: The company's products are expected to be selected for the national centralized procurement of drugsZhitong·Oct 29, 2025 at 02:34 AM688247+2.10%
SINOTHERAPEUTICS: The Sitagliptin Metformin Extended-Release Tablets have received approval from the U.S. FDAZhitong·Oct 20, 2025 at 03:21 AM688247+2.10%
Wu Huafeng, Deputy General Manager of Shanghai SINOTHERAPEUTICS, has resigned early for personal reasonsZhitong·Sep 30, 2025 at 05:02 AM688247+2.10%
SINOTHERAPEUTICS: New specifications for Sitagliptin Metformin Extended-Release Tablets approvedZhitong·Sep 26, 2025 at 03:06 AM688247+2.10%
Zhitong A-share lock-up release overview | August 25Zhitong·Aug 24, 2025 at 08:01 PM300595+0.97%688247+2.10%
31 stocks will face lifting of restrictions next weekZhitong·Aug 22, 2025 at 08:29 AM688439+2.07%688247+2.10%
SINOTHERAPEUTICS: Net profit of 45.5857 million yuan in the first half of 2025, a year-on-year decrease of 15.82%Zhitong·Aug 22, 2025 at 02:59 AM688247+2.10%
SINOTHERAPEUTICS: The controlling shareholder Lianhe Investment voluntarily commits not to reduce its holdings in the company within 2 yearsZhitong·Aug 17, 2025 at 03:39 AM688247+2.10%
SINOTHERAPEUTICS subsidiary Xuantai Pharmaceutical has passed the EU GMP certificationZhitong·Jul 17, 2025 at 02:44 AM688247+2.10%
SINOTHERAPEUTICS: Enzalutamide tablets have received approval number from the U.S. FDAZhitong·Jun 26, 2025 at 02:36 AM688247+2.10%
SINOTHERAPEUTICS: Sales in the U.S. market have not been significantly affected, actively expanding into international marketsZhitong·May 12, 2025 at 05:07 AM688247+2.10%
SINOTHERAPEUTICS: Dapagliflozin Metformin Extended-Release Tablets have received approval from the U.S. FDAZhitong·May 12, 2025 at 02:50 AM688247+2.10%
Changes in some directors, executives, financial officers, and core technical personnel of SINOTHERAPEUTICSZhitong·May 5, 2025 at 03:17 AM688247+2.10%
SINOTHERAPEUTICS shareholders Qi He Chuang Ye completed a reduction of 2.43% of their sharesZhitong·Mar 18, 2025 at 05:51 AM688247+2.10%
